Impact of the incorporation of tyrosine kinase inhibitor agents on the treatment of patients with a diagnosis of advanced renal cell carcinoma: Study based on experience at the Hospital Universitario Central de Asturias

1. Muriel, C.
2. Esteban, E.
3. Corral, N.
4. Fonseca, P.J.
5. Luque, M.
6. Berros, J.P.
7. Fernández, Y.
8. Blay, P.
9. Fra, J.
10. Villanueva, N.
11. Sanmamed, M.
12. Pardo, P.
13. Izquierdo, M.
14. Vieitez, J.M.
15. Estrada, E.
16. Lacave, Á.J.